Poolbeg Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jeremy Skillington

Chief executive officer

UK£362.0k

Total compensation

CEO salary percentage69.1%
CEO tenure3.3yrs
CEO ownership0.2%
Management average tenureless than a year
Board average tenure3.3yrs

Recent management updates

Recent updates

Companies Like Poolbeg Pharma (LON:POLB) Are In A Position To Invest In Growth

Aug 20
Companies Like Poolbeg Pharma (LON:POLB) Are In A Position To Invest In Growth

We're Hopeful That Poolbeg Pharma (LON:POLB) Will Use Its Cash Wisely

Feb 16
We're Hopeful That Poolbeg Pharma (LON:POLB) Will Use Its Cash Wisely

We're Hopeful That Poolbeg Pharma (LON:POLB) Will Use Its Cash Wisely

Oct 05
We're Hopeful That Poolbeg Pharma (LON:POLB) Will Use Its Cash Wisely

We're Hopeful That Poolbeg Pharma (LON:POLB) Will Use Its Cash Wisely

Jun 01
We're Hopeful That Poolbeg Pharma (LON:POLB) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Poolbeg Pharma's (LON:POLB) Cash Burn Situation

Jul 12
Here's Why We're Not Too Worried About Poolbeg Pharma's (LON:POLB) Cash Burn Situation

CEO Compensation Analysis

How has Jeremy Skillington's remuneration changed compared to Poolbeg Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-UK£4m

Mar 31 2024n/an/a

-UK£4m

Dec 31 2023UK£362kUK£250k

-UK£4m

Sep 30 2023n/an/a

-UK£4m

Jun 30 2023n/an/a

-UK£5m

Mar 31 2023n/an/a

-UK£5m

Dec 31 2022UK£310kUK£250k

-UK£5m

Dec 31 2021UK£261kn/a

-UK£3m

Compensation vs Market: Jeremy's total compensation ($USD469.79K) is about average for companies of similar size in the UK market ($USD369.71K).

Compensation vs Earnings: Jeremy's compensation has increased whilst the company is unprofitable.


CEO

Jeremy Skillington (53 yo)

3.3yrs

Tenure

UK£362,000

Compensation

Dr. Jeremy Skillington, Ph D., serves as Chief Executive Officer and since July 19, 2021 as Director at Poolbeg Pharma PLC. He is Vice President of Business Development at Inflazome Ltd.Dr. Skillington se...


Leadership Team

NamePositionTenureCompensationOwnership
Cathal Friel
Executive Chairman of The Board3.7yrsUK£150.00k4.36%
£ 1.8m
Jeremy Skillington
CEO & Directorno dataUK£362.00k0.17%
£ 72.5k
Ian O'Connell
CFO & Directorno dataUK£237.00k1.67%
£ 691.1k
Carol Dalton
Vice President of Investor Relations & Public Relations1.8yrsno datano data
John McEvoy
Senior Vice President & Chief Legal Officerless than a yearno datano data
David Allmond
Chief Business Officerless than a yearno datano data
Ross Crockett
Group Financial Controllerno datano datano data

0.9yrs

Average Tenure

53.5yo

Average Age

Experienced Management: POLB's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Cathal Friel
Executive Chairman of The Board3.7yrsUK£150.00k4.36%
£ 1.8m
Jeremy Skillington
CEO & Director3.3yrsUK£362.00k0.17%
£ 72.5k
Ian O'Connell
CFO & Director3.5yrsUK£237.00k1.67%
£ 691.1k
Luke O'Neill
Independent Non-Executive Director & Member of Scientific Advisory Board3.3yrsUK£40.00kno data
Brendan Buckley
Member of Scientific Advisory Board & Independent Non Executive Director1.9yrsUK£24.00k0.53%
£ 218.4k
Elaine Sullivan
Member of Scientific Advisory Boardno datano datano data
Edward Gibson
Senior Independent Director3.3yrsUK£35.00kno data
Daniel Hoft
Member of Scientific Advisory Board3yrsno datano data

3.3yrs

Average Tenure

60yo

Average Age

Experienced Board: POLB's board of directors are considered experienced (3.3 years average tenure).